impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Letters to the Editor

 

Obinutuzumab in rituximab-refractory or intolerant systemic lupus erythematosus: a real-world case series

1, 2, 3, 4

 

  1. Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa Medical Faculty, Istanbul, Turkey.
  2. Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa Medical Faculty, Istanbul, Turkey.
  3. Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa Medical Faculty, Istanbul, Turkey.
  4. Rheumatology, Department of Internal Medicine, Istanbul University-Cerrahpasa Medical Faculty, Istanbul, Turkey. serdalugurlu@gmail.com

CER19627
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 41779595 [PubMed]

Received: 18/12/2025
Accepted : 10/02/2026
In Press: 04/03/2026

DOI: https://doi.org/10.55563/clinexprheumatol/dmc85l

Rheumatology Article